Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease. (MAESTRO)

NCT02092181 is registered in ClinicalTrials.gov with Daniel Burdick, MD as lead sponsor.

NCT NCT02092181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02092181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease. (MAESTRO)
Lead sponsor
Daniel Burdick, MD
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
July 1, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinsons disease